Drug Companies, Not ‘Middlemen’, Are Responsible For High Drug Prices

As pharmaceutical companies have faced more heat for their pricing practices, they’ve found someone else to blame: “middlemen” who extract discounts from drugmakers. But in fact, if it weren’t for middlemen like wholesalers and pharmacy benefit managers, drug prices would be even higher. When Donald Trump was running for President in 2016, he promised to